MCT2D Resource: Dosing Information for SGLT-2 Inhibitors and GLP-1 Receptor Agonists for Type 2 Diabetes
Updated: 10/16/23
Key dosing information for SGLT2-I and GLP1-RAs including dose escalation, pen and needle RX considerations, proven benefits for ASCVD, CKD, HFrEF, HFpEF, and DKD.
Tags: For Providers, Created By MCT2D, Point-of-care